Wegovy
Signals mentioning Wegovy
- Mounjaro overtakes legacy medicines to become India’s top-selling drug
- HealthifyMe merges with Berry Street, eyes India pharma, insurer and offline growth
- India’s GLP-1 market tops ₹220 crore as tirzepatide surges and semaglutide generics multiply
- Tata Consumer readies nutrition products for India’s GLP-1 weight-loss drug users
- Cipla prioritises Yurpeak as sales nearly double, delaying semaglutide launch
- Pharma-nutrition tie-ups race to capture $150B GLP-1 companion market
- Novo Nordisk's Ozempic, Wegovy sales jump 40% in India after steep price cuts
- GLP-1 wave to redraw India's consumption: snacking down 40-60%, protein and skincare up
- Dove's Real Beauty playbook collides with the Ozempic era